Chronic ethanol attenuates centrally-mediated hypotension elicited via α2-adrenergic, but not I1-imidazoline, receptor activation in female rats

Life Sciences

Volumn 84, Issue 3-4, 2009, Pages 111-118

  El Mas, Mahmoud M ^a   Abdel Rahman, Abdel A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Methyldopa; Ethanol; Female, Rats; Hypotension; Rilmenidine

Indexed keywords

ALCOHOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; IMIDAZOLINE I1 RECEPTOR; METHYLDOPA; RILMENIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CHRONIC DISEASE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HYPOTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; TELEMETRY;

ANIMALS; AREA UNDER CURVE; BLOOD PRESSURE; ETHANOL; FEMALE; HEART RATE; IMIDAZOLINE RECEPTORS; METHYLDOPA; OXAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2;

RATTUS;

EID: 58049128502     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.11.006     Document Type: Article

References (39)

1. Abdel-Rahman A.R.A. Reversal by ethanol of the hypotensive effect of clonidine in conscious spontaneously hypertensive rats. Hypertension 14 5 (1989) 531-541
2. Badoer E., Head G., and Korner P.I. Effects of intracisternal and intravenous alpha-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits. J Cardiovascular Pharmacology 5 5 (1983) 760-767
3. Biaggioni I. Sympathetic control of the circulation in hypertension: lessons from autonomic disorders. Current Opinion in Nephrology and Hypertension 12 2 (2003) 175-180
4. 2-adrenergic drugs: differences between catecholamines and imidazolines. The Journal of Pharmacology and Experimental Therapeutics 230 1 (1984) 232-236
5. Bousquet P., Feldman J., Tibirica E., Bricca G., Greney H., Dontenwill M., Stutzmann J., and Belcourt A. Imidazoline receptors: a new concept in central regulation of the arterial blood pressure. American Journal of Hypertension 5 4 Pt 2 (1992) 47S-50S
6. Chan C.K.S., Sannajust F., and Head G.A. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. The Journal of Pharmacology and Experimental Therapeutics 276 2 (1996) 411-420
7. Collins M.A., Ung-Chhun N., Cheng B.Y., and Pronger D. Brain and plasma tetrahydroisoquinolines in rats: effects of chronic ethanol intake and diet. Journal of Neurochemistry 55 5 (1990) 1507-1514
8. Dupuy O., Bauduceau B., and Mayaudon H. Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patients. American Journal of Hypertension 13 6 Pt 2 (2000) 123S-126S
9. Elghozi J.L., Laude D., and Janvier F. Clonidine reduces blood pressure and heart rate oscillations in hypertensive patients. Journal of Cardiovascular Pharmacology 17 6 (1991) 935-940
10. I-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics 288 2 (1999) 455-462
11. El-Mas M.M., and Abdel-Rahman A.A. Role of the sympathetic control of vascular resistance in ethanol-clonidine hemodynamic interaction in SHRs. Journal of Cardiovascular Pharmacology 34 4 (1999) 589-596
12. El-Mas M.M., and Abdel-Rahman A.A. Sexually dimorphic hemodynamic effects of intragastric ethanol in conscious rats. Clinical and Experimental Hypertension 21 8 (1999) 1429-1445
13. El-Mas M.M., and Abdel-Rahman A.A. Radiotelemetric evaluation of the hemodynamic effects of long-term ethanol in spontaneously hypertensive and Wistar-Kyoto rats. The Journal of Pharmacology and Experimental Therapeutics 292 3 (2000) 944-951
14. 2-receptor binding in Wistar-Kyoto and spontaneously hypertensive rats. Brain Research 900 2 (2001) 324-328
15. El-Mas M.M., and Abdel-Rahman A.A. An association between the estrogen-dependent hypotensive effect of ethanol and an elevated brainstem c-jun mRNA in female rats. Brain Research 912 1 (2001) 79-88
16. El-Mas M.M., and Abdel-Rahman A.A. Effects of chronic ethanol feeding on clonidine-evoked reductions in blood pressure, heart rate, and their variability: time-domain analyses. The Journal of Pharmacology and Experimental Therapeutics 306 1 (2003) 271-278
17. 2-receptor-mediated reductions in blood pressure and hemodynamic variability in hypertensive rats. European Journal of Pharmacology 485 1-3 (2004) 251-262
18. 1-imidazoline sites. The Journal of Pharmacology and Experimental Therapeutics 264 1 (1993) 172-182
19. Girard A., Fevrier B., and Elghozi J.L. Cardiovascular variability after rilmenidine challenge: assessment of acute dosing effects by means of spectral analysis. Fundamental & Clinical Pharmacology 9 4 (1995) 366-371
20. Janssen B.J., Tyssen C.M., and Struyker-Boudier H.A. Modification of circadian blood pressure and heart rate variability by five different antihypertensive agents in spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology 17 3 (1991) 494-503
21. 2A/D-adrenoceptor messenger RNA. Neuroscience 81 3 (1997) 593-597
22. Kohno M., Yasunari K., Murakawa K., Yokokawa K., Horio T., Kurihara N., and Takeda T. Effect on atrial natriuretic peptides of chronic treatment with alpha-methyldopa and hydralazine in spontaneously hypertensive rats. American Journal of Hypertension 3 2 (1990) 111-116
23. Kubo T., and Misu Y. Pharmacological characterization of the α-adrenoceptors responsible for a decrease of blood pressure in the nucleus tractus solitarii of the rat. Naunyn-Schmiedeberg's Archives of Pharmacology 317 2 (1981) 120-125
24. Laurent S., Boutouyrie P., and Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 45 6 (2005) 1050-1055
25. Lokhandwala M.F., Buckley J.P., and Jandhyala B.S. Studies on the mechanism of the cardiovascular effects of methyldopa. European Journal of Pharmacology 37 1 (1976) 79-89
26. 2a-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biological Psychiatry 48 9 (2000) 932-939
27. Puddey I.B., Beilin L.J., and Vandongen R. Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomized controlled trial. Lancet 2 8560 (1987) 647-651
28. Sgoifo A., de Boer S.F., Westenbroek C., Maes F.W., Beldhuis H., Suzuki T., and Koolhaas J.M. Incidence of arrhythmias and heart rate variability in wild-type rats exposed to social stress. American Journal of Physiology 273 4 Pt 2 (1997) H1754-1760
29. Stein P.K., Bosner M.S., Kleiger R.E., and Conger B.M. Heart rate variability: a measure of cardiac autonomic tone. American Heart Journal 127 5 (1994) 1376-1381
30. Sweet C.S. New centrally acting antihypertensive drugs related to methyldopa and clonidine. Hypertension 6 5 Pt 2 (1984) II51-56
31. Szmigielski A., Szmigielska H., and Wejman I. The effect of prolonged ethanol administration on central alpha2-adrenoceptors sensitivity. Polish Journal of Pharmacology and Pharmacy 41 3 (1989) 263-272
32. Timio M., Venanzi S., Gentili S., Ronconi M., Del Re G., and Del Vita M. Reversal of left ventricular hypertrophy after one-year treatment with clonidine: relationship between echocardiographic findings, blood pressure, and urinary catecholamines. Journal of Cardiovascular Pharmacology 10 Suppl 12 (1987) S142-146
33. 2-Adrenoceptors: classification, localization, mechanisms and targets for drugs. Journal of Medicinal Chemistry 25 12 (1982) 1389-1401
34. Tobe S.W., Soberman H., Kiss A., Perkins N., and Baker B. The effect of alcohol and gender on ambulatory blood pressure: results from the Baseline Double Exposure study. American Journal of Hypertension 19 2 (2006) 136-139
35. Tulen J.H., Smeets F.M., Man in 't Veld A.J., van Steenis H.G., van de Wetering B.J., and Moleman P. Cardiovascular variability after clonidine challenge: assessment of dose-dependent temporal effects by means of spectral analysis. Journal of Cardiovascular Pharmacology 22 1 (1993) 112-119
36. van der Maas M.L., Head G.A., and de Jong W. Mechanism of the tachycardia following systemic alpha-methyldopa administration in conscious rats. Journal of Cardiovascular Pharmacology 8 5 (1986) 1014-1019
37. I) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine. Journal of Hypertension 15 2 (1997) 117-125
38. van Zwieten P.A., Thoolen M.J., and Timmermans P.B. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine. Hypertension 6 5 Pt 2 (1984) II28-33
39. Volicer L., Volicer B.J., and Gravras H. The effect of alcohol intake on compliance with antihypertensive treatment. In: Messiha F.S., and Tyner G.S. (Eds). Alcoholism: A perspective (1978), PJD Publishing Co., New York 88-99